SHANGHAI, China & MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: Shanghai Kehua Bio-engineering (Stock Code: 002022) and bioMérieux (Paris:BIM) announce the creation of a Shanghai-based joint venture to which bioMérieux will transfer microplate immunoassay manufacturing currently located at its Boxtel site in the Netherlands.
